Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
1 drugs in development
By Therapeutic Area
top 1
R&D Momentum
35/100
Pipeline Velocity
6/100
Trial Completion Rate
89/100
Pipeline Concentration
50/100
Pipeline Freshness
74/100
Strategic Signals
Activity
Last 14 days
Online Interplay Between Deciding and Acting With Mild Cognitive Impairment
Disentangling the Effects of Daily Stress, Sleep, and Sex Hormones on Accelerated Vascular Aging in Midlife Women
Time Restricted Eating, Eating Behaviors, and Cardiometabolic Risk in Emerging Adult Women
Earlier
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)